Comparative Study of Liraglutide and Insulin Glargine on Glycemic Control and Pancreatic β-Cell Function in db/db Mice

Related articles

04 Sep 2020 : Laboratory Research

Icariin Protects Mouse Insulinoma Min6 Cell Function by Activating the PI3K/AKT Pathway

Tao Zhang, Fen Qiu

DOI: 10.12659/MSM.924453

02 May 2019 : Laboratory Research

Expression of TMEFF2 in Human Pancreatic Cancer Tissue and the Effects of TMEFF2 Knockdown on Cell, Proliferation, and Apoptosis in Human Pancreatic Cell Lines

Kailiang Li, Wenjing Gu, [...] Jie Xu, Aikun Wang, Hongchao Han - Show fewer authors

DOI: 10.12659/MSM.913974

09 May 2019 : Animal Research

Therapeutic Effects of Sleeve Gastrectomy and Ileal Transposition on Type 2 Diabetes in a Non-Obese Rat Model by Regulating Blood Glucose and Reducing Ghrelin Levels

Hui Wang, Xinxin Fa, [...] Wei Qu, Jindong Fu, Kaiyun Fan, Jinxian Liu, Feng Li - Show fewer authors

DOI: 10.12659/MSM.913705

16 Oct 2018 : Laboratory Research

Efficacy and Clinical Value of Liraglutide for Treatment of Diabetes Mellitus Complicated by Non-Alcoholic Fatty Liver Disease

Zhongyong Zhang, Yueying Qi, [...] Wubao Kong, Qianqian Jin, Xiaoyun Wang, Yanfang Dong, Yuansong Wang, Huajun Li - Show fewer authors

DOI: 10.12659/MSM.911062

17 Apr 2018 : Animal Research

Liraglutide Enhances Autophagy and Promotes Pancreatic β Cell Proliferation to Ameliorate Type 2 Diabetes in High-Fat-Fed and Streptozotocin-Treated Mice

Menglin Fan, Hongwei Jiang, [...] Yingyu Zhang, Yujin Ma, Liping Li, Jiannan Wu - Show fewer authors

DOI: 10.12659/MSM.906286

01 Mar 2018 : Laboratory Research

Glutamine Enhances the Hypoglycemic Effect of Insulin in L6 Cells via Phosphatidylinositol-3-Kinase (PI3K)/Protein Kinase B (AKT)/Glucose Transporter 4 (GLUT4) Signaling Pathway

Caijuan Wang, Yujiao Deng, [...] Yenan Yue, Wenting Chen, Yu Zhang, Guifang Shi, Zhongming Wu - Show fewer authors

DOI: 10.12659/MSM.909011

28 Feb 2017 : Clinical Research

Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus

Noriko Ihana-Sugiyama, Ritsuko Yamamoto-Honda, [...] Takehiro Sugiyama, Tetsuro Tsujimoto, Masafumi Kakei, Mitsuhiko Noda - Show fewer authors

DOI: 10.12659/MSMBR.902218

08 Sep 2017 : Animal Research

Glucagon-Like Peptide-1 (GLP-1) Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats

Xiang-Sheng Cai, Zhao-Guang Tan, [...] Jing-Jing Li, Wei-Hong Gao, Shu-Ji Li, Jin-Long Li, Yong-Ming Tang, Hong-Wei Li, Hong-Xiang Hui - Show fewer authors

DOI: 10.12659/MSM.903252

14 Nov 2017 : Animal Research

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Liraglutide Alters Bone Marrow Exosome-Mediated miRNA Signal Pathways in Ovariectomized Rats with Type 2 Diabetes

Jin Li, Ling-Zhi Fu, [...] Lu Liu, Fen Xie, Ru-Chun Dai - Show fewer authors

DOI: 10.12659/MSM.906603

10 Apr 2014 : Original article

Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels

Naro Ohashi, Naoko Tsuji, [...] Yoshitaka Naito, Takamasa Iwakura, Shinsuke Isobe, Masafumi Ono, Tomoyuki Fujikura, Takayuki Tsuji, Yukitoshi Sakao, Hideo Yasuda, Akihiko Kato, Yoshihide Fujigaki - Show fewer authors

DOI: 10.12659/MSM.889872

14 Apr 2014 : Case report

The potent synergistic effects of the combination of liraglutide and canagliflozin on glycemic control and weight loss

David S.H. Bell,

DOI: 10.12659/AJCR.890626

28 Jun 2012

Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs) – induced apoptosis

Yi Zhan, Hui-lin Sun, [...] Hong Chen, Hua Zhang, Jia Sun, Zhen Zhang, De-hong Cai - Show fewer authors

DOI: 10.12659/MSM.883207

01 Feb 2011

Glucagon-like Peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation

Xie Xiao-Yun, Mo Zhao-Hui, [...] Chen Ke, He Hong-Hui, Xie Yan-Hong - Show fewer authors

DOI: 10.12659/MSM.881383

01 Dec 2007

Insulin treatment reduces pre-prandial plasma ghrelin concentrations in children with type 1 diabetes

Ambika Ashraf, Gail Mick, [...] Sreelatha Meleth, Xudong Wang, Kenneth McCormick - Show fewer authors

01 Jul 2005 : Extended abstract from EFAS 2011

Insulin treatment decreases the antioxidant defense mechanism in experimental diabetes.

Anikó Somogyi, Eva Ruzicska, [...] Eva Ruzicska, Agota Ver, Agota Vér, Miklós Tóth - Show fewer authors

01 Aug 2005

Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): The role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress.

Ewa Bojanowska,

01 Feb 2004

Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy

Katarzyna Cypryk, Małgorzata Sobczak, [...] Magdalena Pertyńska-Marczewska, Małgorzata Zawodniak-Szałapska, Wiesław Szymczak, Jan Wilczyński, Andrzej Lewiński - Show fewer authors

01 Mar 2004

The metabolic effects of insulin and rosiglitazone combination therapy in Chinese Type 2 diabetic patients with nephropathy

Norman N. Chan, Peter C.Y. Tong, [...] Wing-Yee So, Wilson Y.S. Leung, Cherry K.P. Chiu, Juliana C.N. Chan - Show fewer authors